TNG908 is an MTAPnull-selective PRMT5 inhibitor that drives tumor regression in MTAP-deleted xenograft models across histologies

Press Release

TNG908 is an MTAPnull-selective PRMT5 inhibitor that drives tumor regression in MTAP-deleted xenograft models across histologies